Expertise in
34
conditions

Dr. Shih J. Wei

Radiation Oncology
Community Howard Regional Health
3500 S Lafountain St, 
Kokomo, IN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
34
conditions
Community Howard Regional Health
3500 S Lafountain St, 
Kokomo, IN 

Overview

Shih Wei is a Radiation Oncologist practicing medicine in Kokomo, Indiana.

Dr. Wei is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 4 clinical trials. Dr. Wei is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in IN

Hospital Affiliations

Orthoindy Hospital
Community Howard Regional Health Inc.
Community Hospital North
Riverview Health
Community Hospital East

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Community Howard Regional Health
3500 S Lafountain St, Kokomo, IN 46902
Other Locations
Community Regional Cancer Cen
7979 N Shadeland Ave, Indianapolis, IN 46250

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Drug, Other, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: August 27, 2026
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
View 3 Less Clinical Trials

1 Total Publications

Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial.
Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: February 13, 2026
Similar Doctors
Expertise in
40
conditions
Dr. Christopher A. Leagre
Radiation Oncology
Expertise in
40
conditions
Dr. Christopher A. Leagre
Radiation Oncology
Referral may be required

Cancer Care Group

6100 W 96th St, Ste 125, 
Indianapolis, IN 
 (36.7 miles away)
317-715-1800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Leagre, MD, is an independent radiation oncologist at Ascension St. Vincent in Indianapolis, Indiana. He delivers radiotherapy such as internal and external beam radiation therapy, brachytherapy and systemic radiation therapy. Dr. Leagre is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Radiation Induced Meningioma, Meningioma, Intraductal Papilloma, and Astrocytoma. Dr. Leagre is board certified in The American Board Of Radiology - Radiation Oncology. Dr. Leagre is currently accepting new patients.

Expertise in
17
conditions
Dr. Tim Lautenschlaeger
Radiation Oncology
Expertise in
17
conditions
Dr. Tim Lautenschlaeger
Radiation Oncology
Referral may be required

IU Health Methodist Hospital

1701 Senate Blvd, 
Indianapolis, IN 
 (45.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Tim Lautenschlaeger is a Radiation Oncologist practicing medicine in Indianapolis, Indiana. Dr. Lautenschlaeger is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Posterior Fossa Tumor. Dr. Lautenschlaeger is currently accepting new patients.

Expertise in
25
conditions
Dr. Stanley S. Givens
Radiation Oncology
Expertise in
25
conditions
Dr. Stanley S. Givens
Radiation Oncology
Referral may be required

Cancer Care Group

6100 W 96th St, Ste 125, 
Indianapolis, IN 
 (36.7 miles away)
317-715-1800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stanley Givens, MD, is an independent radiation oncologist at Ascension St. Vincent in Indianapolis, Indiana. He delivers radiotherapy such as internal and external beam radiation therapy, brachytherapy and systemic radiation therapy. Dr. Givens is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Neuroendocrine Carcinoma of the Cervix. Dr. Givens is board certified in The American Board Of Radiology - Radiation Oncology. Dr. Givens is currently accepting new patients.

Frequently Asked Questions about Dr. Shih J. Wei

How do I make an appointment with Dr. Shih J. Wei?

You can book an appointment with Dr. Shih J. Wei by calling their office at 317-621-4300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shih J. Wei a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shih J. Wei is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shih J. Wei specialize in?

While Dr. Shih J. Wei is a Radiation Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Shih J. Wei participate in research or clinical trials?

Yes. Dr. Shih J. Wei has published 1 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Shih J. Wei's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Shih J. Wei accept my insurance?

Dr. Shih J. Wei accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 317-621-4300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wei's expertise for a condition
ConditionClose
    View All 28 Advanced Conditions
    View All 48 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile